These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 18445541
1. Antimicrobial resistance of rapidly growing mycobacteria in western Taiwan: SMART program 2002. Huang TS, Lee SS, Hsueh PR, Tsai HC, Chen YS, Wann SR, Leu HS, Ko WC, Yan JJ, Yuan SZ, Chang FY, Lu JJ, Wang JH, Wang HK, Liu YC. J Formos Med Assoc; 2008 Apr; 107(4):281-7. PubMed ID: 18445541 [Abstract] [Full Text] [Related]
2. [Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria]. Özkarataş MH, Arslan N, Esen N, Özkütük AA. Mikrobiyol Bul; 2023 Apr; 57(2):220-237. PubMed ID: 37067207 [Abstract] [Full Text] [Related]
3. Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan. Hatakeyama S, Ohama Y, Okazaki M, Nukui Y, Moriya K. BMC Infect Dis; 2017 Mar 07; 17(1):197. PubMed ID: 28270102 [Abstract] [Full Text] [Related]
4. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan. Yang SC, Hsueh PR, Lai HC, Teng LJ, Huang LM, Chen JM, Wang SK, Shie DC, Ho SW, Luh KT. Antimicrob Agents Chemother; 2003 Jun 07; 47(6):1958-62. PubMed ID: 12760874 [Abstract] [Full Text] [Related]
6. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing]. Gui J, Wang F, Hong CY, Li JL, Liang J. Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug 07; 36(8):567-71. PubMed ID: 24252731 [Abstract] [Full Text] [Related]
8. Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel. Cavusoglu C, Gurpinar T, Ecemis T. New Microbiol; 2012 Jan 07; 35(1):73-6. PubMed ID: 22378556 [Abstract] [Full Text] [Related]
9. Antimicrobial susceptibility testing of Mycobacteroides (Mycobacterium) abscessus complex, Mycolicibacterium (Mycobacterium) fortuitum, and Mycobacteroides (Mycobacterium) chelonae. Aono A, Morimoto K, Chikamatsu K, Yamada H, Igarashi Y, Murase Y, Takaki A, Mitarai S. J Infect Chemother; 2019 Feb 07; 25(2):117-123. PubMed ID: 30447882 [Abstract] [Full Text] [Related]
10. Drug susceptibility testing of rapidly growing mycobacteria in extrapulmonary tuberculosis. Gole GV, Set R, Khan N, Shastri J. Indian J Tuberc; 2016 Apr 07; 63(2):119-22. PubMed ID: 27451822 [Abstract] [Full Text] [Related]
11. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran. Heidarieh P, Mirsaeidi M, Hashemzadeh M, Feizabadi MM, Bostanabad SZ, Nobar MG, Hashemi Shahraki A. Microb Drug Resist; 2016 Mar 07; 22(2):172-8. PubMed ID: 26468990 [Abstract] [Full Text] [Related]
13. Evaluation of the broth microdilution method using 2,3-diphenyl-5-thienyl-(2)-tetrazolium chloride for rapidly growing mycobacteria susceptibility testing. Lee SM, Kim Jm, Jeong J, Park YK, Bai GH, Lee EY, Lee MK, Chang CL. J Korean Med Sci; 2007 Oct 07; 22(5):784-90. PubMed ID: 17982223 [Abstract] [Full Text] [Related]
14. High Rates of Antimicrobial Resistance in Rapidly Growing Mycobacterial Infections in Taiwan. Tu HZ, Lee HS, Chen YS, Lee SS. Pathogens; 2022 Aug 25; 11(9):. PubMed ID: 36145400 [Abstract] [Full Text] [Related]
15. Antibiotic resistance in Mycobacterium Abscessus and Mycobacterium Fortuitum isolates from Malaysian patients. Jayasingam SD, Zin T, Ngeow YF. Int J Mycobacteriol; 2017 Aug 25; 6(4):387-390. PubMed ID: 29171453 [Abstract] [Full Text] [Related]
16. Skin and soft-tissue infections due to rapidly growing mycobacteria: An overview. Kumar C, Shrivastava K, Singh A, Chauhan V, Varma-Basil M. Int J Mycobacteriol; 2021 Aug 25; 10(3):293-300. PubMed ID: 34494569 [Abstract] [Full Text] [Related]
17. Drug Susceptibility Testing of 31 Antimicrobial Agents on Rapidly Growing Mycobacteria Isolates from China. Pang H, Li G, Zhao X, Liu H, Wan K, Yu P. Biomed Res Int; 2015 Aug 25; 2015():419392. PubMed ID: 26351633 [Abstract] [Full Text] [Related]
18. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria. Wallace RJ, Brown-Elliott BA, Crist CJ, Mann L, Wilson RW. Antimicrob Agents Chemother; 2002 Oct 25; 46(10):3164-7. PubMed ID: 12234839 [Abstract] [Full Text] [Related]
19. High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria. Shen GH, Wu BD, Hu ST, Lin CF, Wu KM, Chen JH. Int J Antimicrob Agents; 2010 Apr 25; 35(4):400-4. PubMed ID: 20138481 [Abstract] [Full Text] [Related]
20. In Vitro Antimicrobial Activities of Tigecycline, Eravacycline, Omadacycline, and Sarecycline against Rapidly Growing Mycobacteria. Zhang T, Du J, Dong L, Wang F, Zhao L, Jia J, Wang C, Cheng M, Yu X, Huang H. Microbiol Spectr; 2023 Feb 14; 11(1):e0323822. PubMed ID: 36475850 [Abstract] [Full Text] [Related] Page: [Next] [New Search]